An overactive gene appears to cause some prostate cancers to transform from a typical tumor type to a much more aggressive form of the disease, according to new research at Weill Cornell Medicine.
The New York State Cooperative Wildlife Health Program – a partnership among Cornell and New York state to track and manage wildlife diseases – will receive $4.8 million over the five years.
A deep-freezing technique known as cryoablation is a viable alternative to traditional surgery in many early-stage breast cancers according to Weill Cornell Medicine research.
For the average person, the time before the start of the holiday season is the low point in an annual weight gain pattern that peaks during the holidays and takes nearly half a year to fully shed.
Research involving cancer-targeting silica particles, known as Cornell dots, has shown that the particles can neutralize nutrient-deprived cancer cells by a cell-death process called ferroptosis.
Cornell’s New York State Agricultural Experiment Station in Geneva is poised to expand its food development and technology commercialization capabilities with $1 million in new state funding.
An innovative method that uses human embryonic stem cells to model type 2 diabetes caused by genetic mutations may enable researchers to identify drugs that could treat the disease.
New research by Weill Cornell Medicine investigators could offer researchers a new scientific avenue to pursue treatments for X-linked chromosomal diseases in females such as Rett syndrome.
